Lindbrook Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $6.06K | Buy |
209
+155
| +287% | +$4.49K | ﹤0.01% | 1876 |
|
2024
Q4 | $2.01K | Sell |
54
-10
| -16% | -$371 | ﹤0.01% | 2304 |
|
2024
Q3 | $3.11K | Buy |
64
+10
| +19% | +$485 | ﹤0.01% | 2205 |
|
2024
Q2 | $2.16K | Sell |
54
-9
| -14% | -$360 | ﹤0.01% | 2325 |
|
2024
Q1 | $2.77K | Sell |
63
-32
| -34% | -$1.41K | ﹤0.01% | 2130 |
|
2023
Q4 | $5.88K | Buy |
95
+41
| +76% | +$2.54K | ﹤0.01% | 1801 |
|
2023
Q3 | $2.48K | Hold |
54
| – | – | ﹤0.01% | 2048 |
|
2023
Q2 | $3.1K | Hold |
54
| – | – | ﹤0.01% | 1990 |
|
2023
Q1 | $2.03K | Buy |
54
+12
| +29% | +$450 | ﹤0.01% | 2242 |
|
2022
Q4 | $1.18K | Sell |
42
-102
| -71% | -$2.86K | ﹤0.01% | 2426 |
|
2022
Q3 | $4K | Buy |
144
+68
| +89% | +$1.89K | ﹤0.01% | 1726 |
|
2022
Q2 | $3K | Sell |
76
-29
| -28% | -$1.15K | ﹤0.01% | 1736 |
|
2022
Q1 | $4K | Buy |
105
+29
| +38% | +$1.11K | ﹤0.01% | 1666 |
|
2021
Q4 | $2K | Buy |
76
+34
| +81% | +$895 | ﹤0.01% | 1740 |
|
2021
Q3 | $1K | Hold |
42
| – | – | ﹤0.01% | 1667 |
|
2021
Q2 | $1K | Hold |
42
| – | – | ﹤0.01% | 1698 |
|
2021
Q1 | $1K | Hold |
42
| – | – | ﹤0.01% | 1657 |
|
2020
Q4 | $1K | Hold |
42
| – | – | ﹤0.01% | 1561 |
|
2020
Q3 | $1K | Hold |
42
| – | – | ﹤0.01% | 1498 |
|
2020
Q2 | $1K | Hold |
42
| – | – | ﹤0.01% | 1505 |
|
2020
Q1 | $1K | Buy |
+42
| New | +$1K | ﹤0.01% | 1377 |
|